ALIMTA® (pemetrexed disodium) as second-line treatment ofnon-small-cell lung cancer: a phase II study
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/14/3/455/554835/mdg099.pdf
Reference19 articles.
1. Chemotherapy in non small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials;The Non-Small Cell Lung Cancer Collaborative Group;Br Med J,1995
2. Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life;Cullen;J Clin Oncol,1999
3. Chemotherapy for advanced non-small-cell lung cancer: modest progress;Shepherd;many choices. J Clin Oncol,2000
4. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients;Le Chevalier;J Clin Oncol,1994
5. Randomized study of paclitaxel–cisplatin versus cisplatin–etoposide in patients with advanced non-small cell lung cancer;Giaccone;J Clin Oncol,1998
Cited by 107 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer;Expert Opinion on Pharmacotherapy;2018-10-24
2. Lung cancer specific and reduction-responsive chimaeric polymersomes for highly efficient loading of pemetrexed and targeted suppression of lung tumor in vivo;Acta Biomaterialia;2018-04
3. Hepatotoxicity in Advanced Lung Adenocarcinoma: A Retrospective Study of 2108 Cases;Journal of Cancer;2018
4. Systemic Options for Second-Line Therapy and Beyond;IASLC Thoracic Oncology;2018
5. Cancer bronchique non à petites cellules de stade IV sans addiction oncogénique : traitements en 2 e ligne et au-delà;Revue des Maladies Respiratoires Actualités;2017-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3